8/103 sources · 2 publishersUpdated Nov 13, 00:16 UTC
Windward Bio prices US IPO at $17 per share, raises $175 million
+1 new source since this summary was written
Windward Bio Group AG priced its Nasdaq debut at $17 per share, selling about 10.3 million shares. The offering generated $175 million, and Sanofi committed to a $50 million private placement, bringing total proceeds to roughly $225 million. Trading under the symbol WWB begins on Friday. The company is backed by Novo Holdings and other biotech investors.
Why it matters
The proceeds provide capital for Windward Bio's antibody drug development programs. The IPO gives investors a new listed biotech exposure and sets the initial market valuation for the company.
Key facts
- 1The IPO price was $17 per share. finance.yahoo.com
- 2About 10.3 million shares were sold in the offering. finance.yahoo.com
- 3The IPO raised $175 million in gross proceeds. finance.yahoo.com
- 4Sanofi agreed to purchase $50 million of shares and pre‑funded warrants in a private placement. finance.yahoo.com
- 5Total proceeds from the IPO and private placement are expected to be $225 million. investing.com
- 6Windward Bio has raised $310 million in equity financing to date. finance.yahoo.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.